AMN HEALTHCARE SERVICES INC (AMN) Stock Fundamental Analysis
NYSE:AMN - New York Stock Exchange, Inc. - US0017441017 - Common Stock - Currency: USD
We assign a fundamental rating of 4 out of 10 to AMN. AMN was compared to 106 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of AMN get a neutral evaluation. Nothing too spectacular is happening here. AMN has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
AMN had positive earnings in the past year.
In the past year AMN had a positive cash flow from operations.
Of the past 5 years AMN 4 years were profitable.
In the past 5 years AMN always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of -6.08%, AMN is doing worse than 68.87% of the companies in the same industry.
AMN has a worse Return On Equity (-20.80%) than 63.21% of its industry peers.
AMN has a Return On Invested Capital (4.75%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AMN is above the industry average of 8.79%.
The last Return On Invested Capital (4.75%) for AMN is well below the 3 year average (13.14%), which needs to be investigated, but indicates that AMN had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.08% | ||
| ROE | -20.8% | ||
| ROIC | 4.75% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
1.3 Margins
AMN's Operating Margin of 4.01% is in line compared to the rest of the industry. AMN outperforms 55.66% of its industry peers.
In the last couple of years the Operating Margin of AMN has declined.
AMN has a Gross Margin of 30.81%. This is comparable to the rest of the industry: AMN outperforms 55.66% of its industry peers.
In the last couple of years the Gross Margin of AMN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.01% | ||
| PM (TTM) | N/A | ||
| GM | 30.81% |
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AMN is creating some value.
The number of shares outstanding for AMN has been increased compared to 1 year ago.
The number of shares outstanding for AMN has been reduced compared to 5 years ago.
AMN has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.43 indicates that AMN is not a great score, but indicates only limited risk for bankruptcy at the moment.
AMN has a Altman-Z score (2.43) which is comparable to the rest of the industry.
AMN has a debt to FCF ratio of 4.41. This is a neutral value as AMN would need 4.41 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 4.41, AMN is doing good in the industry, outperforming 69.81% of the companies in the same industry.
A Debt/Equity ratio of 1.49 is on the high side and indicates that AMN has dependencies on debt financing.
AMN's Debt to Equity ratio of 1.49 is on the low side compared to the rest of the industry. AMN is outperformed by 70.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.49 | ||
| Debt/FCF | 4.41 | ||
| Altman-Z | 2.43 |
ROIC/WACC0.65
WACC7.35%
2.3 Liquidity
A Current Ratio of 1.09 indicates that AMN should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.09, AMN is doing worse than 69.81% of the companies in the same industry.
A Quick Ratio of 1.09 indicates that AMN should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.09, AMN is doing worse than 62.26% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.09 |
3. Growth
3.1 Past
The earnings per share for AMN have decreased strongly by -59.44% in the last year.
Measured over the past 5 years, AMN shows a small growth in Earnings Per Share. The EPS has been growing by 0.80% on average per year.
Looking at the last year, AMN shows a very negative growth in Revenue. The Revenue has decreased by -21.26% in the last year.
AMN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.07% yearly.
EPS 1Y (TTM)-59.44%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-43.18%
Revenue 1Y (TTM)-21.26%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-10.21%
3.2 Future
Based on estimates for the next years, AMN will show a very strong growth in Earnings Per Share. The EPS will grow by 22.82% on average per year.
The Revenue is expected to grow by 4.40% on average over the next years.
EPS Next Y-66.47%
EPS Next 2Y-26.67%
EPS Next 3Y-6.6%
EPS Next 5Y22.82%
Revenue Next Year-10.19%
Revenue Next 2Y-3.53%
Revenue Next 3Y-0.73%
Revenue Next 5Y4.4%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 5.59, which indicates a rather cheap valuation of AMN.
Based on the Price/Earnings ratio, AMN is valued cheaper than 98.11% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.29, AMN is valued rather cheaply.
The Price/Forward Earnings ratio is 16.66, which indicates a correct valuation of AMN.
AMN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AMN is cheaper than 73.58% of the companies in the same industry.
AMN is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.08, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.59 | ||
| Fwd PE | 16.66 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, AMN is valued cheaply inside the industry as 89.62% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, AMN is valued cheaper than 99.06% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.95 | ||
| EV/EBITDA | 5.97 |
4.3 Compensation for Growth
AMN's earnings are expected to decrease with -6.60% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)6.94
EPS Next 2Y-26.67%
EPS Next 3Y-6.6%
5. Dividend
5.1 Amount
No dividends for AMN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
18.49
+0.27 (+1.48%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners108.48%
Inst Owner Change0%
Ins Owners0.39%
Ins Owner Change5.1%
Market Cap706.32M
Analysts69.23
Price Target32.2 (74.15%)
Short Float %10.12%
Short Ratio3.93
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)28.79%
Min EPS beat(2)5.34%
Max EPS beat(2)52.24%
EPS beat(4)4
Avg EPS beat(4)21.5%
Min EPS beat(4)0.39%
Max EPS beat(4)52.24%
EPS beat(8)8
Avg EPS beat(8)15.49%
EPS beat(12)12
Avg EPS beat(12)13.71%
EPS beat(16)16
Avg EPS beat(16)15.17%
Revenue beat(2)2
Avg Revenue beat(2)3.07%
Min Revenue beat(2)1.38%
Max Revenue beat(2)4.75%
Revenue beat(4)2
Avg Revenue beat(4)1.18%
Min Revenue beat(4)-0.96%
Max Revenue beat(4)4.75%
Revenue beat(8)4
Avg Revenue beat(8)0.55%
Revenue beat(12)8
Avg Revenue beat(12)1.43%
Revenue beat(16)12
Avg Revenue beat(16)2.56%
PT rev (1m)0%
PT rev (3m)-21.07%
EPS NQ rev (1m)-2.94%
EPS NQ rev (3m)-41.07%
EPS NY rev (1m)-26.37%
EPS NY rev (3m)-32.87%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)1.86%
Revenue NY rev (1m)-0.19%
Revenue NY rev (3m)-1.44%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.59 | ||
| Fwd PE | 16.66 | ||
| P/S | 0.24 | ||
| P/FCF | 2.95 | ||
| P/OCF | 2.2 | ||
| P/B | 1 | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.97 |
EPS(TTM)3.31
EY17.9%
EPS(NY)1.11
Fwd EY6%
FCF(TTM)6.27
FCFY33.91%
OCF(TTM)8.39
OCFY45.36%
SpS78.11
BVpS18.5
TBVpS-14.98
PEG (NY)N/A
PEG (5Y)6.94
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.08% | ||
| ROE | -20.8% | ||
| ROCE | 6.41% | ||
| ROIC | 4.75% | ||
| ROICexc | 4.77% | ||
| ROICexgc | 15.29% | ||
| OM | 4.01% | ||
| PM (TTM) | N/A | ||
| GM | 30.81% | ||
| FCFM | 8.03% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
ROICexc(3y)13.46%
ROICexc(5y)13.47%
ROICexgc(3y)46.83%
ROICexgc(5y)47.63%
ROCE(3y)17.73%
ROCE(5y)17.46%
ROICexcg growth 3Y-38.44%
ROICexcg growth 5Y-11.09%
ROICexc growth 3Y-36.92%
ROICexc growth 5Y-11.74%
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
F-Score3
Asset Turnover1.24
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.49 | ||
| Debt/FCF | 4.41 | ||
| Debt/EBITDA | 3.6 | ||
| Cap/Depr | 46.55% | ||
| Cap/Sales | 2.71% | ||
| Interest Coverage | 1.96 | ||
| Cash Conversion | 109.15% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.09 | ||
| Altman-Z | 2.43 |
F-Score3
WACC7.35%
ROIC/WACC0.65
Cap/Depr(3y)57.01%
Cap/Depr(5y)52.87%
Cap/Sales(3y)2.35%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-59.44%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-43.18%
EPS Next Y-66.47%
EPS Next 2Y-26.67%
EPS Next 3Y-6.6%
EPS Next 5Y22.82%
Revenue 1Y (TTM)-21.26%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-10.21%
Revenue Next Year-10.19%
Revenue Next 2Y-3.53%
Revenue Next 3Y-0.73%
Revenue Next 5Y4.4%
EBIT growth 1Y-64.61%
EBIT growth 3Y-38.24%
EBIT growth 5Y-7.5%
EBIT Next Year91.73%
EBIT Next 3Y33.74%
EBIT Next 5YN/A
FCF growth 1Y-10.21%
FCF growth 3Y-1.64%
FCF growth 5Y4.92%
OCF growth 1Y-13.9%
OCF growth 3Y1.61%
OCF growth 5Y7.34%